Literature DB >> 16822254

Levetiracetam pharmacokinetics in neonates at birth.

Karel Allegaert1, Liesbeth Lewi, Gunnar Naulaers, Lieven Lagae.   

Abstract

Based on blood sampling in a formula-fed pair of twins, the estimated serum half-life of levetiracetam (LEV) at birth is 16-18 h.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16822254     DOI： 10.1111/j.1528-1167.2006.00576.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN： 0013-9580            Impact factor:   5.864


  4 in total

1.  Population pharmacokinetics modeling of levetiracetam in Chinese children with epilepsy.

Authors:  Ying-hui Wang; Li Wang; Wei Lu; De-wei Shang; Min-ji Wei; Ye Wu
Journal:  Acta Pharmacol Sin       Date:  2012-06       Impact factor: 6.150

Review 2.  Clinical pharmacokinetics of new-generation antiepileptic drugs at the extremes of age: an update.

Authors:  Domenico Italiano; Emilio Perucca
Journal:  Clin Pharmacokinet       Date:  2013-08       Impact factor: 6.447

3.  Evaluation of cefotaxime and desacetylcefotaxime concentrations in cord blood after intrapartum prophylaxis with cefotaxime.

Authors:  Jacques Lepercq; Jean Marc Treluyer; Christelle Auger; Josette Raymond; Elisabeth Rey; Thomas Schmitz; Vincent Jullien
Journal:  Antimicrob Agents Chemother       Date:  2009-03-23       Impact factor: 5.191

4.  Levetiracetam in the treatment of epilepsy.

Authors:  Bassel Abou-Khalil
Journal:  Neuropsychiatr Dis Treat       Date:  2008-06       Impact factor: 2.570
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.